Accelerating Drug Discovery: Leveraging XtalPi’s Intelligent Software for Faster Breakthroughs

▤ Summary

XtalPi presents its intelligent software stack as a way to speed up drug discovery by combining AI, quantum physics, robotics, and wet-lab validation. The article highlights several products, including PatSight for chemical structure extraction, MolValley for molecular data management, XMolGen for generative molecular design, and XFEP for high-throughput affinity prediction. It positions the platform as a way to reduce cycle times, improve data quality, and lower the cost of bringing therapies to market. The piece also notes XtalPi’s global R&D footprint and its Hong Kong Stock Exchange listing as context for the company’s scale and technical depth.

▦ Linked Companies

XtalPi

$10M to $25M